lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin

X Yin, H Zhang, J Wang, Y Bian, Q Jia, Z Yang… - Discover Oncology, 2024 - Springer
In this study, we investigated the role of the newly discovered lncRNA FLJ20021 in laryngeal
cancer (LC) and its resistance to cisplatin treatment. We initially observed elevated lncRNA …

Predicting survival of advanced laryngeal squamous cell carcinoma: comparison of machine learning models and Cox regression models

YF Zhang, YJ Shen, Q Huang, CP Wu, L Zhou… - Scientific Reports, 2023 - nature.com
Laryngeal squamous cell carcinoma (LSCC) is a common tumor type. High recurrence rates
remain an important factor affecting the survival and quality of life of advanced LSCC …

Identifying key pathogenic mechanisms and potential intervention targets for recurrence after laryngeal cancer treatment through bioinformatics screening

L Liu, J Wu - Translational Cancer Research, 2024 - pmc.ncbi.nlm.nih.gov
Background Laryngeal cancer (LC), a prevalent malignant tumor of the head and neck, is
characterized by a high rate of postoperative recurrence and significant treatment …

Роль вирусов папилломы человека при раке гортани и рецидивирующем респираторном папилломатозе: эпидемиологические и клинические аспекты

ДВ Холопов, ЛВ Лялина, ЭЭ Топузов… - Опухоли головы и …, 2024 - ogsh.abvpress.ru
Аннотация За последние 10 лет число случаев рака гортани в мире увеличилось на
23%. заболеваемость раком гортани и связанная с ним смертность в последние годы …

[引用][C] Metastatik olmayan larenks kanseri tanılı hastalarda postoperatif tedavi modalitelerinin etkinliklerinin retrospektif karşılaştırılması

A Gökmen - 2024 - Bursa Uludağ Üniversitesi